Skip to content

Antibiotic Therapy: Recommended Durations and Doses in 2026

A Practical Guide for Healthcare Professionals

Table of Contents

Prescribe Less, But Better: Optimizing Antibiotic Treatment Duration and Dosing

Background and Context

The rational reduction of antibiotic treatment durations has emerged as a key strategy in the global fight against antimicrobial resistance, a major public health concern. Recent medical literature demonstrates that in uncomplicated, microbiologically confirmed infections with a favorable clinical course, short-course regimens achieve outcomes comparable to traditional prolonged treatment protocols.

Benefits of an Optimized Approach

Shortened antibiotic regimens offer several significant clinical and epidemiological advantages: a reduction in the incidence of adverse drug reactions, decreased selective pressure on resistant bacterial strains, improved treatment adherence, and a reduced environmental impact from antibiotic excretion and dissemination into the ecosystem.

Purpose of This Review

This article provides a concise, up-to-date summary of recommended antibiotic treatment durations in 2025, intended for general practitioners, emergency physicians, internists, and other healthcare professionals involved in antibiotic prescribing. It is based on the most recent French reference guidelines, including those from the Société de Pathologie Infectieuse de Langue Française (SPILF), the Haute Autorité de Santé (HAS), and relevant specialist societies.

The goal is to provide clear, current decision-making benchmarks for rational, effective, and responsible antibiotic prescribing.

1. RESPIRATORY INFECTIONS

Community-Acquired Pneumonia (CAP)

Clinical CourseRecommended Duration
Clinical improvement by day 33 days
Clinical improvement between day 3 and day 55 days
CAP in the ICU or other complex situations7 days

Aspiration Pneumonia

Clinical SituationRecommended Duration
Patient stable by day 55 days
Patient not yet stabilized7 days

Atypical Infections (Whooping Cough / Mycoplasma pneumoniae / Chlamydia pneumoniae)

DrugRecommended Duration
Azithromycin 500mg/day3 days
Clarithromycin (500mg, 2 tabs/day)7 days

Other Lower Respiratory Tract Infections

ConditionRecommended Duration
Hospital-acquired pneumonia or VAP (excluding empyema, abscess, immunocompromised)7 days
Acute exacerbation of COPD (GOLD III–IV)5 days
Purulent pleuritis (empyema)14 days (after last drainage)

2. ENT AND CERVICAL INFECTIONS

Acute Otitis Media

PopulationRecommended Duration
Adult5 days
Child ≤ 2 years10 days

Group A Streptococcal Pharyngitis (Strep Throat)

DrugRecommended Duration
Amoxicillin6 days
Cefpodoxime (penicillin allergy)5 days
Clarithromycin (penicillin allergy)5 days

Sinusitis

Type / DrugRecommended Duration
Maxillary sinusitis (Amoxicillin 3g/day)7 days
Maxillary sinusitis, 2nd/3rd-gen. cephalosporin oral (cefuroxime 500mg, 3 tabs/day)5 days
Maxillary sinusitis, Pristinamycin4 days
Child10 days
Non-maxillary sinusitis, amoxicillin-clavulanate7 days
Non-maxillary sinusitis, 2nd/3rd-gen. cephalosporin oral (cefuroxime 500mg, 3 tabs/day)5 days
Non-maxillary sinusitis, fluoroquinolone (moxifloxacin 400 mg/day)5 days
Clinical note: Antibiotic withholding may be considered in non-severe cases (children > 2 years)

Cervical Infections

ConditionRecommended Duration
Lymphadenitis (adult)7 days
Lymphadenitis (child)10 days
Peritonsillar, retropharyngeal or parapharyngeal abscess (drained)7 days
Peritonsillar, retropharyngeal or parapharyngeal abscess (undrained)10 days
Severe forms (cellulitis, descending necrotizing mediastinitis)14 days post-surgery

3. URINARY TRACT INFECTIONS

Uncomplicated Acute Cystitis (women)

DrugRecommended Duration
Fosfomycin trometamolSingle dose
Nitrofurantoin (100mg, 3 tabs/day)3 days
Pivmecillinam3 days

Cystitis at Risk of Complications or Healthcare-Associated

DrugRecommended Duration
Fosfomycin trometamolDay 1 – Day 3 – Day 5
Cotrimoxazole (Bactrim)5 days
Other agents7 days

Cystitis in Men

DrugRecommended Duration
Fosfomycin trometamolDay 1 – Day 3 – Day 5
Other agents7 days

Acute Pyelonephritis

TypeRecommended Duration
Uncomplicated (fluoroquinolone)7 days
At risk of complications or healthcare-associated10 days
Unfavorable course or abscessSpecialist referral

Male Genital Infections

ConditionRecommended Duration
Acute prostatitis (fluoroquinolone)14 days
Acute epididymitis / orchitis (fluoroquinolone)10 days

4. SEXUALLY TRANSMITTED INFECTIONS

ConditionRecommended Treatment
Bacterial vaginosis (metronidazole 500 mg twice daily)7 days
Vulvovaginitis (metronidazole 500 mg twice daily)7 days
Gonococcal or chlamydial urethritis / cervicitisSingle-dose ceftriaxone + doxycycline 7 days
Early syphilis (primary or secondary)Single-dose benzathine penicillin G

Pelvic Inflammatory Disease (women)

ConditionRecommended Treatment
Uncomplicated PIDSingle-dose ceftriaxone (1g IM) + doxycycline 10 days (100 mg twice daily) + metronidazole 10 days (500 mg three times daily)
Complicated PIDCeftriaxone (1g IM) until improvement (max 7 days) + doxycycline 14 days (100 mg twice daily) + metronidazole 14 days (500 mg three times daily)

5. SKIN AND SOFT TISSUE INFECTIONS

ConditionRecommended Duration
Simple furuncle (boil)No oral antibiotic
Simple impetigoNo oral antibiotic
Contaminated wound5 days
Drained abscess5 days
Animal bite5 days
Non-necrotizing bacterial cellulitis, severe impetigo, furunculosis7 days

6. BONE AND JOINT INFECTIONS

Septic Arthritis

PathogenRecommended Duration
S. aureus, Enterobacteriaceae6 weeks
Streptococci4 weeks
N. gonorrhoeae7 days

Other Bone and Joint Infections

ConditionRecommended Duration
Spondylodiscitis (without hardware or with hardware replacement)6 weeks
Septic bursitis14 days

7. DIABETIC FOOT

Clinical SituationRecommended Duration
Osteitis without amputation6 weeks
Osteitis at the amputation margin3 weeks
Complete amputation with no associated infection5 days
Amputation with skin infection7 days (up to 14 days if slow clinical response)

8. BACTEREMIA AND DEVICE-RELATED INFECTIONS

Uncomplicated Bacteremia

PathogenRecommended Duration
Enterobacteriaceae, Streptococci, Enterococci7 days
Staphylococcus aureus, S. lugdunensis14 days

Catheter-Related Bloodstream Infections (after removal + negative blood cultures)

PathogenRecommended Duration
Coagulase-negative staphylococci3 days
Other bacteria7 days
S. aureus14 days
Candida spp.14 days
Septic thrombophlebitis21 days

Endocarditis

PathogenRecommended Duration
Streptococci4 to 6 weeks (depending on valve involvement)
Enterococci6 weeks (depending on valve involvement)
S. aureus4 to 6 weeks (depending on valve involvement)

9. GASTROINTESTINAL INFECTIONS

ConditionRecommended Duration
Acute travelers’ diarrheaAzithromycin, single dose
Shigella/Campylobacter diarrhea (children)3 days
Yersinia diarrhea (children)5 days
Salmonella diarrhea (children)3 or 5 days depending on indication and patient profile
Clostridium difficile infection10 days
Non-operated, non-perforated appendicitis7 days
Localized peritonitis3 days
Generalized peritonitis4 days
Uncomplicated diverticulitisNo antibiotic (monitoring)
Complicated diverticulitis/abscess3 days if drained / 7 days otherwise
Drained liver abscess3 weeks
Undrained liver abscess≥ 28 days

Helicobacter pylori eradication (10 days)

First-line regimen:

DrugDosage
PPI (omeprazole or equivalent)40 mg × 2/day
Amoxicillin2 g in 2 doses/day
Clarithromycin1 g in 2 doses/day
Metronidazole1 g in 2 doses/day

Alternative regimen (bismuth quadruple therapy / Pylera):

DrugDosage
PPI (omeprazole or equivalent)40 mg × 2/day
PYLERA (3 capsules, 4 times/day)
Bismuth1680 mg in 4 doses/day
Tetracycline1500 mg in 4 doses/day
Metronidazole1500 mg in 4 doses/day

KEY MESSAGES FOR PRACTICE

Systematic reassessment

Reassess any antibiotic therapy at 48–72 hours

Clinical adjustment

Adjust the duration to the clinical course, not to habit

Quality of care

Short durations are an indicator of quality of care

Specialist advice

If in doubt or in a complex situation: seek specialist advice

Bibliography

SPILF – Société de Pathologie Infectieuse de Langue Française

Recommendations from the Info-antibio document no. 107 – December 2025, prepared by the GPIP group, published in Médecine et Maladies Infectieuses – Formation.

CBIP (Centre Belge d'Information Pharmacothérapeutique). Available at: https://www.cbip.be/fr/

VIDAL. VIDAL - La base de données en ligne des prescripteurs libéraux. Paris: VIDAL; 2025. Available at: https://www.vidal.fr/

This article is for information only and does not replace advice from a health professional.

Read next

Enfant malade avec soignant et sa maman
News

Chronic illness in children: what home care for better support?

Chronic illnesses in children are not limited to physical conditions alone. They also include developmental and mental health disorders, sometimes having an equally significant impact on schooling

By CSB Klinik

Expert adviceMembers— Members only (free sign-up)

Joint Pain and Digestive Disorders: How Cupping Therapy Can Help

Cupping therapy is a very ancient practice that is still used today, particularly in traditional Chinese medicine. It consists of creating suction on the skin to stimulate blood and energy circulation.

By Manon COLLER

femme malade grippe covid gastro
News

Flu, Gastroenteritis, COVID… What to Do When It’s Spreading at Work?

Today, workplace health has become a major concern for all companies, regardless of their sector. The COVID-19 crisis reminded us starkly that contagious diseases can spread very quickly and seriously disrupt an organisation’s operations.

By Dr. Patrick Ndeba

News

Erectile Dysfunction in Men: Treatment and Prevention

Erectile dysfunction, also called ED, refers to a persistent difficulty in achieving or maintaining an erection sufficient for satisfactory sexual activity.

By CSB Klinik

Newsletter

Subscribe to our free newsletter

Get CSB Klinik news and our experts' advice by email.

Newsletter